CD8 + T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types.
Frontiers in immunology（2022）
摘要
CFR is a newly found and simple parameter that can be used for identifying patients unlikely to benefit from immunotherapy. Future studies are needed to confirm this finding.
更多查看译文
关键词
CD8+ T cell,cancer-associated fibroblast,immunotherapy,predictive biomarker,prognostic biomarker
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要